Buscar
Mostrando ítems 1-10 de 76
Pharmacovigilance Committee for COVID-19 vaccine (ChAdOx1-S [recombinant]) and its contribution for an effective benefit-risk assessment
(Fiocruz/Instituto de Tecnologia em Imunobiológicos, 2022)
Establishment of a reference material for potency and identity assays of recombinant COVID-19 vaccine active ingredients, intermediary and final products
(Fiocruz/Instituto de Tecnologia em Imunobiológicos, 2022)
Situational strategic planning of the pharmacovigilance of Covid-19 vaccine (ChAdOx1-S [recombinant]) at Bio-Manguinhos/Fiocruz
(Fiocruz/Instituto de Tecnologia em Imunobiológicos, 2021)
Amplifying immunogenicity of prospective Covid-19 vaccines by glycoengin- eering the coronavirus glycan-shield to present α-gal epitopes
The many carbohydrate chains on Covid-19 coronavirus SARS-CoV-2 and its S-protein form a glycanshield that masks antigenic peptides and decreases uptake of inactivated virus or S-protein vaccines by APC.
Studies on ...
Safety, tolerability, and immunogenicity of a recombinant adenovirus type-5 vectored COVID-19 vaccine: a dose-escalation, open-label, non-randomised, first-in-human trial
Background A vaccine to protect against COVID-19 is urgently needed. We aimed to assess the safety, tolerability, and
immunogenicity of a recombinant adenovirus type-5 (Ad5) vectored COVID-19 vaccine expressing the ...
Continued Process Verification for COVID-19 Vaccine Formulation and Packaging (recombinant)
(Fiocruz/Instituto de Tecnologia em Imunobiológicos, 2022)
Live attenuated infectious bronchitis virus vaccines in poultry: modifying local viral populations dynamics
(MDPI, 2020)
Simple Summary
Infectious bronchitis (IB) is one of the more prevalent diseases in poultry, and it is caused by a virus belonging to the Coronaviridae family, the infectious bronchitis virus (IBV), a Gammacoronavirus ...
Lactiplantibacillus plantarum as a potential adjuvant and delivery system for the development of sars-cov-2 oral vaccines
(Multidisciplinary Digital Publishing Institute, 2021-03-26)
The most important characteristics regarding the mucosal infection and immune responses against the Acute Respiratory Syndrome coronavirus 2 (SARS-CoV-2) as well as the current vaccines against coronavirus disease 2019 ...